MarketCap
Facebook
X
Telegram
Dynavax Technologies Corporation Balance Sheet 2024-2008 | DVAX
Brief overview of Dynavax Technologies Corporation's balance sheet strength
Balance sheet changes are traced across five available annual reports between 2020 and 2024.
Total assets increased by +179.2%, from $353.3 million to $986.3 million. A CAGR near 29.3% points to substantial expansion.
Liabilities grew more slowly than assets: +32.2% versus +179.2%. Expansion relied more on equity, improving funding quality.
The equity-to-assets ratio is 60.5%, compared with 16.6% five periods ago. The balance sheet has a substantial internal cushion.
Cash exceeds interest-bearing debt, producing net debt of -$65.3 million. The balance sheet therefore carries a net cash position.
Cash represents 9.7% of assets versus 9.1% initially, showing how the immediate liquidity reserve changed.
The balance sheet carries negative retained earnings of -$903.3 million. The figure may result from accumulated losses or an active capital return policy.
Balance sheet takeaway
Dynavax Technologies Corporation's financial position is positive on balance sheet evidence. Growth in resources has not undermined capital strength.
Annual Balance Sheet Dynavax Technologies Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-65.3 M | -116 M | -166 M | -399 M | 151 M | 250 M | 148 M | -26.6 M | -24.3 M | -44.8 M | 33.2 M | -23.1 M | -7.6 M | -19.1 M | - | - | - |
Long Term Debt |
26.4 M | 29.7 M | 32.8 M | 34.3 M | 180 M | 179 M | 101 M | - | - | - | 9.56 M | - | - | - | - | - | - |
Long Term Debt Current |
4.18 M | 4.5 M | 3.63 M | 2.58 M | 3.25 M | 3.04 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 218 M | 110 M | 643 K | 443 K | 769 K | 17.5 M | 2.14 M | 5.91 M | 7 M | - | - | - |
Total Current Liabilities |
78.6 M | 62.2 M | 150 M | 556 M | 77.4 M | 53 M | 38 M | 18.6 M | 20 M | 28.8 M | 20.3 M | 16.2 M | 19 M | 27.2 M | 13.9 M | - | - |
Total Liabilities |
389 M | 375 M | 405 M | 817 M | 295 M | 271 M | 148 M | 19.2 M | 20.5 M | 29.6 M | 37.8 M | 18.3 M | 24.9 M | 34.2 M | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | 2.65 M | 5.86 M | 6.12 M | 6.78 M | 4.21 M | 1.43 M | - | - |
Retained Earnings |
-903 M | -931 M | -924 M | -1.22 B | -1.29 B | -1.22 B | -1.07 B | -907 M | -812 M | -700 M | -593 M | -502 M | -435 M | -366 M | -317 M | - | - |
Total Assets |
986 M | 997 M | 986 M | 1.04 B | 353 M | 279 M | 211 M | 219 M | 110 M | 217 M | 138 M | 205 M | 140 M | 134 M | 84.2 M | - | - |
Cash and Cash Equivalents |
95.9 M | 150 M | 202 M | 436 M | 32.1 M | 39.9 M | 49.3 M | 26.6 M | 24.3 M | 44.8 M | 49.5 M | 23.1 M | 7.6 M | 31.9 M | 22.5 M | 36.7 M | 28.1 M |
Book Value |
597 M | 622 M | 581 M | 222 M | 58.7 M | 8.29 M | 63.1 M | 200 M | 89.2 M | 187 M | 100 M | 186 M | 115 M | 99.9 M | 84.2 M | - | - |
Total Shareholders Equity |
597 M | 622 M | 581 M | 222 M | 58.7 M | 8.29 M | 63.1 M | 200 M | 89.2 M | 187 M | 100 M | 186 M | 115 M | 99.9 M | 52.1 M | 6.38 M | 16.2 M |
All numbers in USD currency
Quarterly Balance Sheet Dynavax Technologies Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
24 M | 24.7 M | 25.5 M | 26.4 M | 26.6 M | 27.5 M | 28.6 M | 29.7 M | 30.7 M | 31.5 M | 32.1 M | 32.8 M | 33.1 M | - | 34.3 M | 34.3 M | 220 M | 220 M | 180 M | 180 M | 180 M | 180 M | 180 M | 179 M | 179 M | 179 M | 179 M | 101 M | 101 M | 101 M | 101 M | - | - | - | - | - | - | - | - | - | - | 7.96 M | 8.91 M | 9.56 M | 9.56 M | 9.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
412 M | 424 M | 415 M | 389 M | 381 M | 373 M | 368 M | 375 M | 368 M | 359 M | 406 M | 405 M | 499 M | - | 721 M | 817 M | 852 M | 565 M | 390 M | 295 M | 295 M | 295 M | 295 M | 271 M | 271 M | 271 M | 271 M | 148 M | 148 M | 148 M | 148 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 29.6 M | 29.6 M | 29.6 M | 29.6 M | 37.8 M | 37.8 M | 37.8 M | 37.8 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 34.2 M | 34.2 M | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 55.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.76 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 5.86 M | 5.86 M | 5.86 M | 5.86 M | 6.12 M | 6.12 M | 6.12 M | 6.12 M | 6.78 M | 6.78 M | 6.78 M | 6.78 M | 4.21 M | 4.21 M | 4.21 M | 4.21 M |
Retained Earnings |
-954 M | -981 M | -999 M | -903 M | -910 M | -928 M | -939 M | -931 M | -931 M | -945 M | -949 M | -924 M | -992 M | - | -1.18 B | -1.22 B | -1.32 B | -1.29 B | -1.29 B | -1.29 B | -1.29 B | -1.29 B | -1.29 B | -1.22 B | -1.22 B | -1.22 B | -1.22 B | -1.07 B | -1.07 B | -1.07 B | -1.07 B | -907 M | -907 M | -907 M | -907 M | -812 M | -812 M | -812 M | -812 M | -700 M | -700 M | -700 M | -700 M | -593 M | -593 M | -593 M | -593 M | -502 M | -502 M | -502 M | -502 M | -435 M | -435 M | -435 M | -435 M | -366 M | -366 M | -366 M | -366 M |
Total Assets |
947 M | 918 M | 946 M | 986 M | 1.06 B | 1.02 B | 987 M | 997 M | 973 M | 936 M | 970 M | 986 M | 999 M | - | 1.01 B | 1.04 B | 920 M | 648 M | 490 M | 353 M | 353 M | 353 M | 353 M | 279 M | 279 M | 279 M | 279 M | 211 M | 211 M | 211 M | 211 M | 219 M | 219 M | 219 M | 219 M | 110 M | 110 M | 110 M | 110 M | 217 M | 217 M | 217 M | 217 M | 138 M | 138 M | 138 M | 138 M | 205 M | 205 M | 205 M | 205 M | 140 M | 140 M | 140 M | 140 M | 134 M | 134 M | 134 M | 134 M |
Cash and Cash Equivalents |
160 M | 99.1 M | 51.7 M | 95.9 M | 119 M | 113 M | 132 M | 150 M | 155 M | 227 M | 174 M | 202 M | 199 M | 249 M | 179 M | 436 M | 246 M | 130 M | 79.1 M | 32.1 M | 32.1 M | 32.1 M | 32.1 M | 39.9 M | 39.9 M | 39.9 M | 39.9 M | 49.3 M | 49.3 M | 49.3 M | 49.3 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 24.3 M | 24.3 M | 24.3 M | 24.3 M | 44.8 M | 44.8 M | 44.8 M | 44.8 M | 49.5 M | 49.5 M | 49.5 M | 49.5 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M | 31.9 M | 31.9 M | 31.9 M | 31.9 M |
Book Value |
534 M | 494 M | 531 M | 597 M | 681 M | 643 M | 618 M | 622 M | 605 M | 577 M | 564 M | 581 M | 501 M | - | 287 M | 222 M | 67.6 M | 83.4 M | 99.8 M | 58.7 M | 58.7 M | 58.7 M | 58.7 M | 8.29 M | 8.29 M | 8.29 M | 8.29 M | 63.1 M | 63.1 M | 63.1 M | 63.1 M | 200 M | 200 M | 200 M | 200 M | 89.2 M | 89.2 M | 89.2 M | 89.2 M | 187 M | 187 M | 187 M | 187 M | 100 M | 100 M | 100 M | 100 M | 186 M | 186 M | 186 M | 186 M | 115 M | 115 M | 115 M | 115 M | 99.9 M | 99.9 M | 134 M | 134 M |
Total Shareholders Equity |
534 M | 494 M | 531 M | 597 M | 681 M | 643 M | 618 M | 622 M | 605 M | 577 M | 564 M | 581 M | 501 M | 423 M | 287 M | 222 M | 67.6 M | 83.4 M | 99.8 M | 58.7 M | 58.7 M | 58.7 M | 58.7 M | 8.29 M | 8.29 M | 8.29 M | 8.29 M | 63.1 M | 63.1 M | 63.1 M | 63.1 M | 200 M | 200 M | 200 M | 200 M | 89.2 M | 89.2 M | 89.2 M | 89.2 M | 187 M | 187 M | 187 M | 187 M | 100 M | 100 M | 100 M | 100 M | 186 M | 186 M | 186 M | 186 M | 115 M | 115 M | 115 M | 115 M | 99.9 M | 99.9 M | 99.9 M | 99.9 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Dynavax Technologies Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Canada
China
USA
France
Singapore
Britain
Germany
Israel
Russia
Belgium
Niderland
Irlanda
